Patents by Inventor LouJin Song

LouJin Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Cardiac Differentiation of Human Induced Pluripotent Stem Cells
    Publication number: 20230374460
    Abstract: The present invention relates to monolayer cardiac differentiation techniques utilizing defined conditions providing feeder-free monolayer culture systems, serum-based or serum free, and applicable to both healthy control and patient derived stem cells.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 23, 2023
    Inventors: Masayuki Yazawa, LouJin Song
  • COMPOUNDS AND METHODS FOR INHIBITING CDK5 ALLEVIATE CARDIAC PHENOTYPES IN TIMOTHY SYNDROME AND RELATED CONDITIONS
    Publication number: 20200188469
    Abstract: The present invention relates to compounds and methods for inhibiting CDK5 or the CDK5 pathway for treating long QT syndrome (LQTS), and in particular Timothy Syndrome (TS). Additionally, the invention relates to small molecule and gene therapy based therapies and combinations for treating Timothy Syndrome (TS), and related channelopathies.
    Type: Application
    Filed: April 3, 2018
    Publication date: June 18, 2020
    Inventors: Masayuki YAZAWA, LouJin SONG
  • THERAPEUTIC SIGMA 1 RECEPTOR AGONISTS FOR TREATING LONG QT SYNDROME TYPE 1, TYPE 2, TYPE 6, TYPE 8 AND RELATED CHANNELOPATHIES
    Publication number: 20200030262
    Abstract: The present invention relates to compounds and methods for increasing or agonizing Sigma 1 Receptors and its pathway for treating long QT syndrome (LQTS), and in particular Timothy Syndrome (TS), LQT8, LQT1, LQT2, and LQT6. Additionally, the invention relates to small molecule based therapies and combinations for treating Timothy Syndrome (TS), LQT8, LQT1, LQT2, LQT6 and related channelopathies.
    Type: Application
    Filed: October 4, 2019
    Publication date: January 30, 2020
    Inventors: Masayuki Yazawa, LouJin Song, Kumi Morikawa, Jose Quejada, Ramsey Bekdash
  • Methods for Cardiac Differentiation of Human Induced Pluripotent Stem Cells
    Publication number: 20180327717
    Abstract: The present invention relates to monolayer cardiac differentiation techniques utilizing defined conditions providing feeder-free monolayer culture systems, serum-based or serum free, and applicable to both healthy control and patient derived stem cells.
    Type: Application
    Filed: August 31, 2016
    Publication date: November 15, 2018
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Masayuki Yazawa, LouJin Song